Clinical analysis on diagnostic accuracy of Bosch Vivalytic SARS-CoV-2 point-of-care test and evaluation of cycle threshold at admission for COVID-19 risk assessment.

Lukas Andreas HegerNils ElsenMarina RiederNadine GauchelUrte SommerwerckChristoph BodeDaniel DuerschmiedMark OetteIngo Ahrens

Published in: BMC infectious diseases (2022)

Our data indicate that POC testing with Bosch Vivalytic SARS-CoV-2 is a valid strategy to identify COVID-19 patients and decrease turnaround time to definite COVID-19 diagnosis. Also, our data suggest that age at admission possibly with CT value as a combined parameter could be a promising tool for risk assessment of increased length of hospital stay and severity of disease in COVID-19 patients.

Keyphrases

sars cov
risk assessment
respiratory syndrome coronavirus
electronic health record
emergency department
human health
heavy metals
big data
computed tomography
image quality
contrast enhanced
data analysis
magnetic resonance
dual energy
adverse drug
machine learning
positron emission tomography